Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately.
International
●World Health Organization (WHO): Classification of tumours – Urinary and male genital tumours, 5th edition (2022)
•WHO: Classification of tumours of the urinary system and male genital organs – Part A: Renal, penile, and testicular tumours (2022)
●International Society of Urological Pathology (ISUP): Report from the consultation conference on molecular pathology of urogenital cancers (2020)
●ISUP: Testicular cancer consultation conference recommendations for the reporting and staging of testicular germ cell tumors (2017)
Canada
●Cancer Care Ontario (CCO): Guidelines and advice for complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum (2019)
●CCO: Guidelines and advice for the management of stage I seminoma (2014)
●CCO: Guidelines and advice on surveillance programs for early stage nonseminomatous testicular cancer (2011)
●CCO: Guidelines and advice on PET imaging in testicular cancer (2009)
●CCO: Guidelines and advice for the management of stage I nonseminomatous testicular cancer (2008)
United States
●National Cancer Institute (NCI): Testicular cancer screening – Health professional version (updated 2022)
●NCI: Testicular cancer treatment – Health professional version (updated 2022)
●American College of Radiology (ACR): ACR Appropriateness Criteria on staging and surveillance of testicular cancer (revised 2021)
●American Urological Association (AUA): Guideline for the diagnosis and treatment of early stage testicular cancer (2019)
●US Preventive Services Task Force (USPSTF): Final recommendation statement on testicular cancer – Screening (2011)
●American Society of Clinical Oncology (ASCO): Clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors (2010)
Europe
●European Association of Urology (EAU): Guidelines on testicular cancer, update (2023)
●European Society for Medical Oncology (ESMO)-European Reference Network on Rare Adult Cancers (EURACAN): Testicular seminoma and non-seminoma – Clinical practice guideline for diagnosis, treatment, and follow-up (2022)
●European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT)/Paediatric Rare Tumours Network - European Registry (PARTNER): Consensus recommendations for the diagnosis and therapy of sex cord stromal tumors in children and adolescents (2021)
●ESMO: Consensus conference guidelines on testicular germ cell cancer – Diagnosis, treatment, and follow-up (2018)
United Kingdom
●Consensus statement on the development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK (2018)
●Evidence-based pragmatic guidelines for the follow-up of testicular cancer ─ Optimising the detection of relapse (2008)
●National Academy of Clinical Biochemistry (NACB) Laboratory Medicine: Practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers (2008)
Australia–New Zealand
●Australia and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP): Recommendations and resources
●Healthy Male (Andrology Australia): Clinical summary guide on testicular cancer supplement (2018)
•Healthy Male (Andrology Australia): Clinical summary guide on testicular cancer (2018)
